Monographie - Telavancin hydrochloride

Poslední aktualizace :
08/05/2024

Telavancin hydrochloride

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Vibativ

Didžioji Britanija, Jungtinės Amerikos Valstijos, Kanada

Bibliografija : Telavancin hydrochloride

	Tipas	Leidinys
2006	Žurnalas	Gu Z, Wong A, Raquinio E, Nguyen A. Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags. Hosp Pharm 2015 ; 50, 7: 609-614.
3254	Žurnalas	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3260	Laboratorija	Telavancin (Vibativ®) - Summary of Products characteristics Astellas Pharma Europe 2011
3327	Žurnalas	LaPlante K.L, Woodmansee S, Mermel L.A. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions. Am J Health-Syst Pharm 2012 ; 69:1405-1409
3835	Žurnalas	Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C. Chemical Stability of Telavancin in Elastomeric Pumps. Current Ther Res 2015 ; 77: 99-104.
3839	Žurnalas	Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. Current Ther Res 2015 ; 77: 105-110.

Mentions Légales